MFC Industrial Ltd (MIL.N)
|Market Cap (Mil.):||$566.10|
|Shares Outstanding (Mil.):||62.55|
DUBLIN - Elan's chief executive said he has not spoken to one shareholder who views Royalty Pharma's bid for the company as credible and that it had nothing to do with Monday's deal with fellow drugmaker Theravance.
DUBLIN - Elan considered buying U.S. investment firm Royalty Pharma last year, six months before Royalty made its approach for the Irish drugmaker, the offer document for the bid showed on Thursday.
* Royalty submits offer document, will only offer fair price
* Royalty had urged shareholders to tender at $11.75 or $12
DUBLIN/NEW YORK, April 15 - Royalty Pharma's sweetened its bid for Irish drugmaker Elan, heaping pressure on its management to open its books to the U.S. investment firm in the hope of a better offer, analysts and shareholders said on Monday.
DUBLIN/ NEW YORK - U.S. investment firm Royalty Pharma launched a cash offer on Monday for Elan worth up to $7.3 billion, improving on its initial proposal to take over the Irish drugmaker and the lucrative royalty rights on its main drug.
|GFI Group Inc. (GFIG.N)||$4.34||0.00|
Earnings vs. Estimates
Analyst Research Reports
Provider: Pechala's Reports
MFC Industrial Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: S&P Capital IQ Quantitative Report
Provider: Wright Reports
Validea Guru Analysis Report for MIL. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.